EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION STATUS: DOES YOUNGER MEAN MORE FREQUENTLY MUTATED?

被引:1
|
作者
Wojcik, P. [1 ]
Krawczyk, P. [2 ]
Chorostowska-Wynimko, J. [3 ]
Reszka, K. [4 ]
Duk, K. [3 ]
Muszczynska-Bernhard, B. [5 ]
Pankowski, J. [6 ]
Wojas-Krawczyk, K. [2 ]
Czyzewicz, G. [7 ]
Ramlau, R. [8 ]
Skoczek, M. [7 ]
Grenda, A. [2 ]
Orlowski, T. [3 ]
Grodzki, T. [9 ]
Piwowar, M. [10 ]
Roszkowski-Sliz, K. [3 ]
Milanowski, J. [2 ]
机构
[1] Oncogene Diagnost LLC, PL-31546 Krakow, Poland
[2] Med Univ Lublin, Dept Pneumonol Oncol & Allergol, PL-20950 Lublin, Poland
[3] Natl Inst TB & Lung Dis, PL-01138 Warsaw, Poland
[4] Genet & Immunol Lab Genim LLC, PL-20609 Lublin, Poland
[5] Lower Silesian Ctr Lung Dis, Dept Pathol, PL-53439 Wroclaw, Poland
[6] Pulm Hosp, Dept Pathol, PL-34500 Zakopane, Poland
[7] John Paul 2 Hosp, Dept Oncol, PL-31202 Krakow, Poland
[8] Poznan Univ Med Sci, Dept Clin Oncol, PL-61701 Poznan, Poland
[9] Pomeranian Med Univ, Dept Thorac Surg & Transplantat, PL-70204 Szczecin Zdunowo, Poland
[10] Jagiellonian Univ, Coll Med, Dept Bioinformat & Telemed, PL-31007 Krakow, Poland
关键词
CELL LUNG-CANCER; ADENOCARCINOMA;
D O I
10.1515/bjmg-2017-0029
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
引用
收藏
页码:89 / 90
页数:2
相关论文
共 50 条
  • [21] Does epidermal growth factor receptor status predict activity of cetuximab in colorectal cancer patients?
    José Baselga
    Nature Clinical Practice Oncology, 2005, 2 (6): : 284 - 285
  • [22] A novel method for detection of mutation in epidermal growth factor receptor
    Zhao, Jinyin
    Zhao, Jing
    Huang, Jie
    Chen, Yan
    Jiang, Jun
    Wu, Weili
    Wang, Pengzhi
    Liu, Licheng
    Li, Longyun
    Wu, Lin
    Wang, Mengzhao
    Chen, Weijun
    LUNG CANCER, 2011, 74 (02) : 226 - 232
  • [23] Histologic transformation of epidermal growth factor receptor-mutated lung cancer
    Fujimoto, Daichi
    Akamatsu, Hiroaki
    Morimoto, Takeshi
    Wakuda, Kazushige
    Sato, Yuki
    Kawa, Yoshitaka
    Yokoyama, Toshihide
    Tamiya, Motohiro
    Hiraoka, Ryota
    Shingu, Naoki
    Ikeda, Hideki
    Tamiya, Akihiro
    Kanazu, Masaki
    Miyauchi, Eisaku
    Miura, Satoru
    Yanai, Masaaki
    Yomota, Makiko
    Morinaga, Ryotaro
    Yokoi, Takashi
    Hata, Akito
    Suzuki, Hidekazu
    Matsumoto, Hirotaka
    Sakata, Shinya
    Furuya, Naoki
    Harutani, Yuhei
    Nakachi, Ichiro
    Otsuki, Ayumu
    Uematsu, Shinya
    Hara, Satoshi
    Yokoo, Keiki
    Sugimoto, Takeya
    Yamamoto, Nobuyuki
    EUROPEAN JOURNAL OF CANCER, 2022, 166 : 41 - 50
  • [24] Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA)
    Kimura, H.
    Suminoe, M.
    Kasahara, K.
    Sone, T.
    Araya, T.
    Tamori, S.
    Koizumi, F.
    Nishio, K.
    Miyamoto, K.
    Fujimura, M.
    Nakao, S.
    BRITISH JOURNAL OF CANCER, 2007, 97 (06) : 778 - 784
  • [25] The comparison of genomic instability between epidermal growth factor receptor(EGFR) mutation status of lung adenocarcinoma
    Lai, Yi-Ling
    Yuan, Shin-Sheng
    Chen, Hsuan-Yu
    Yu, Sung-Liang
    Li, Ker-Chau
    Yang, Pan-Chyr
    CANCER RESEARCH, 2011, 71
  • [26] Epidermal growth factor receptor mutated lung cancers: Looking beyond adenocarcinomas
    Zanwar, Saurabh
    INDIAN JOURNAL OF CANCER, 2021, 58 (01) : 3 - 4
  • [27] Prognostic role of epidermal growth factor receptor mutation status in patients with de novo lung adenocarcinoma
    Li, Bo
    Ren, Xiaolu
    Guo, Hongxia
    Guo, Yi
    Han, Fei
    Wen, Xiaolian
    Wu, Jing
    Li, Xiaomin
    Ren, Yuejun
    Hu, Xiaoyun
    Liu, Zhihong
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (03) : 1549 - 1558
  • [28] Dietary factors and the risk of lung cancer by epidermal growth factor receptor mutation status and histological subtypes
    Yin, Xin
    Lai, Gillianne Geet Yi
    Seow, Adeline
    Tan, Daniel Shao Weng
    Lim, Darren Wan-Teck
    Seow, Wei Jie
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [29] Therapeutic Approaches for the Treatment of Epidermal Growth Factor Receptor Mutated Lung Cancer
    Sanchala, Dhaval
    Bhatt, Lokesh K.
    Prabhavalkar, Kedar S.
    CURRENT CANCER DRUG TARGETS, 2018, 18 (08) : 773 - 791
  • [30] Correlation of epidermal growth factor receptor mutation status in plasma and tissue samples of patients with lung cancer
    Son, C.
    ANNALS OF ONCOLOGY, 2019, 30